Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Symptomatic Superficial Vein Thrombosis”

3 trials

Showing 3 of 3 results

Large-scale testing (Phase 3)Study completedNCT02123524
What this trial is testing

Rivaroxaban Anticoagulation for Superficial Vein Thrombosis

Who this might be right for
Symptomatic Superficial Vein Thrombosis
McMaster University 85
Not applicableStudy completedNCT00818688
What this trial is testing

POST (Prospective Observational Superfial Thrombophlebitis)

Who this might be right for
Thrombophlebitis
Centre Hospitalier Universitaire de Saint Etienne 844
Large-scale testing (Phase 3)Study completedNCT00443053
What this trial is testing

Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)

Who this might be right for
Thrombosis, Venous
GlaxoSmithKline 3,002

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation